The Role of Human Papilloma Virus (HPV) Infection in Non-Anogenital Cancer and the Promise of Immunotherapy: A Review

REFERENCES

• Human Papillomavirus–Associated Cancers—United States, 2004–2008 [Internet]. Centers Dis Control Prev 2012 [cited 2013 Jul 4]. Available from: http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm6115a2.htm
   Google Scholar
• Genital HPV Infection-Fact Sheet. Centers for Disease Control; 2013.
   Google Scholar
• Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113:3036–3046.
   PubMed Web of Science ®Google Scholar
• Assmann G, Sotlar K. [HPV-associated squamous cell carcinogenesis]. Pathol 2011;32:391–398.
   Google Scholar
• Al-Azmi H, Hanafy H. Human papillomavirus: Manifestations, prevention and treatment: an overview. Gulf J Dermatol Venereol 2012;19:1–29.
   Google Scholar
• Weiss RA. On viruses, discovery, and recognition. Cell 2008;135:983–986.
   Google Scholar
• Hariri S, Dunne E, Saraiya M, Chapter 5: Human Papillomavirus. VPD Surveill Man 5th ed.
   Google Scholar
• Molano M, Van den Brule A, Plummer M, Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol 2003;158:486–494.
   PubMed Web of Science ®Google Scholar
• Zhang B, Chen W, Roman A. The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci USA 2006;103:437–442.
   PubMed Web of Science ®Google Scholar
• Faridi R, Zahra A, Khan K, Idrees M. Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virol J 2011;8:269.
   PubMed Web of Science ®Google Scholar
• Dyson N, Howley PM, Münger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934–937.
   PubMed Web of Science ®Google Scholar
• Cervarix Provides Cross-Protection Against Other Types of HPV: CancerConnect News [Internet]. Cancer Connect. [cited 2013 May 19]. Available from: http://news.cancerconnect.com/cervarix-provides-cross-protection-against-other-types-of-hpv/
   Google Scholar
• CDC - Human Papillomavirus (HPV) - Vaccine [Internet]. CDC-HPV Vaccines. 2013 [cited 2013 May 8]. Available from: http://www.cdc.gov/hpv/vaccine.html
   Google Scholar
• De Lima Rocha MG, Faria FL, Gonçalves L, Prevalence of DNA-HPV in male sexual partners of HPV-infected women and concordance of viral types in infected couples. PLoS ONE 2012;7:e40988.
   Google Scholar
• Incassati A, Patel D, McCance DJ. Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6. Oncogene 2006;25:2444–2451.
   PubMed Web of Science ®Google Scholar
• Syrjänen KJ, Pyrhönen S, Syrjänen SM, Lamberg MA. Immunohistochemical demonstration of human papilloma virus (HPV) antigens in oral squamous cell lesions. Br J Oral Surg. 1983;21:147–153.
   PubMedGoogle Scholar
• Chang F, Syrjänen S, Nuutinen J, Detection of human papillomavirus (HPV) DNA in oral squamous cell carcinomas by in situ hybridization and polymerase chain reaction. Arch Dermatol Res 1990;282:493–497.
   PubMedGoogle Scholar
• D'Souza G, Kreimer AR, Viscidi R, Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944–1956.
   PubMed Web of Science ®Google Scholar
• Zandberg DP, Bhargava R, Badin S, Cullen KJ. The role of human papillomavirus in nongenital cancers. CA Cancer J Clin 2013;63:57–81.
   PubMed Web of Science ®Google Scholar
• Vidal L, Gillison ML. Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin North Am 2008;22:1125–1142, vii.
   PubMed Web of Science ®Google Scholar
• Ritchie JM, Smith EM, Summersgill KF, Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003;104:336–344.
   PubMed Web of Science ®Google Scholar
• Beachler DC, Weber KM, Margolick JB, Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol. Biomarkers Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 2012;21:122–133.
   Google Scholar
• Gillison ML, D'Souza G, Westra W, Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407–420.
   PubMed Web of Science ®Google Scholar
• Fakhry C, Westra WH, Li S, Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261–269.
   PubMed Web of Science ®Google Scholar
• Hafkamp HC, Manni JJ, Haesevoets A, Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008;122:2656–2664.
   PubMed Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R, Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35.
   PubMed Web of Science ®Google Scholar
• Rischin D, Young RJ, Fisher R, Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol Off J Am Soc Clin Oncol 2010;28:4142–4148.
   PubMed Web of Science ®Google Scholar
• Posner MR, Lorch JH, Goloubeva O, Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol Off J Eur Soc Med Oncol ESMO 2011;22:1071–1077.
   PubMed Web of Science ®Google Scholar
• Ragin CCR, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007;121:1813–1820.
   PubMed Web of Science ®Google Scholar
• Syrjänen KJ. Condylomatous changes in neoplastic bronchial epithelium. Report of a case. Respir Int Rev Thorac Dis 1979;38:299–304.
   Google Scholar
• Syrjänen KJ. Epithelial lesions suggestive of a condylomatous origin found closely associated with invasive bronchial squamous cell carcinomas. Respir Int Rev Thorac Dis 1980;40:150–160.
   Google Scholar
• Syrjänen KJ. Bronchial squamous cell carcinomas associated with epithelial changes identical to condylomatous lesions of the uterine cervix. Lung 1980;158:131–142.
   Google Scholar
• Ciotti M, Giuliani L, Ambrogi V, Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer. Oncol Rep 2006;16:183–189.
   Google Scholar
• Wang Y, Wang A, Jiang R, Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China. Oncol Rep 2008;20:333–339.
   PubMed Web of Science ®Google Scholar
• Srinivasan M, Taioli E, Ragin CC. Human papillomavirus type 16 and 18 in primary lung cancers–a meta-analysis. Carcinogenesis 2009;30:1722–1728.
   Google Scholar
• Baba M, Castillo A, Koriyama C, Human papillomavirus is frequently detected in gefitinib-responsive lung adenocarcinomas. Oncol Rep 2010;23:1085–1092.
   Google Scholar
• Aguayo F, Anwar M, Koriyama C, Human papillomavirus-16 presence and physical status in lung carcinomas from Asia. Infect Agent Cancer 2010;5:20.
   Google Scholar
• Zhang J, Wang T, Han M, Variation of human papillomavirus 16 in cervical and lung cancers in Sichuan, China. Acta Virol 2010;54:247–253.
   Google Scholar
• Joh J, Jenson AB, Moore GD, Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol 2010;89:222–226.
   PubMed Web of Science ®Google Scholar
• Zhang E-Y, Tang X-D. Human papillomavirus type 16/18 oncoproteins: potential therapeutic targets in non-smoking associated lung cancer. Asian Pac J Cancer Prev APJCP 2012;13:5363–5369.
   Google Scholar
• Muñoz JP, González C, Parra B, Functional interaction between human papillomavirus type 16 E6 and E7 oncoproteins and cigarette smoke components in lung epithelial cells. PLoS ONE 2012;7:e38178.
   Google Scholar
• Koshiol J, Rotunno M, Gillison ML, Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst 2011;103:501–507.
   PubMedGoogle Scholar
• Syrjänen K. Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res 2012;32:3235–3250.
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone A, Krapcho M, SEER Cancer Statistics Review, 1975–2010 [Internet]. SEER Stat Fact Sheets Esophagus. [cited 2013 Jul 4]. Available from: http://seer.cancer.gov/statfacts/ html/esoph.html
   Google Scholar
• Syrjänen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002;55:721–728.
   PubMed Web of Science ®Google Scholar
• Gao G-F, Roth MJ, Wei W-Q, No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: result from a cross-sectional study in a high-risk region of China. Int J Cancer 2006;119:1354–1359.
   PubMed Web of Science ®Google Scholar
• Yahyapour Y, Shamsi-Shahrabadi M, Mahmoudi M, High-risk and low-risk human papillomavirus in esophageal squamous cell carcinoma at mazandaran, Northern Iran. Pathol Oncol Res POR 2012;19:385–391.
   Google Scholar
• Gupta N, Barwad A, Rajwanshi A, Kochhar R. Prevalence of human papilloma virus in esophageal carcinomas: a polymerase chain reaction-based study. Acta Cytol 2012;56:80–84.
   PubMed Web of Science ®Google Scholar
• Liyanage SS, Segelov E, Garland SM, Role of human papillomaviruses in esophageal squamous cell carcinoma. Asia Pac J Clin Oncol 2013;9:12–28.
   Google Scholar
• Sitas F, Egger S, Urban MI, InterSCOPE study: associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst 2012;104:147–158.
   PubMedGoogle Scholar
• Al Moustafa A-E. Involvement of human papillomavirus infections in prostate cancer progression. Med Hypotheses 2008;71:209–211.
   PubMedGoogle Scholar
• Sfanos KS, Sauvageot J, Fedor HL, A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 2008;68:306–320.
   PubMed Web of Science ®Google Scholar
• Bergh J, Marklund I, Gustavsson C, No link between viral findings in the prostate and subsequent cancer development. Br J Cancer 2007;96:137–139.
   PubMedGoogle Scholar
• Noel J, Whitaker, Wendy K. Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer. Prostate 2013;73:236–241.
   Google Scholar
• Aglianò AM, Gradilone A, Gazzaniga P, High frequency of human papillomavirus detection in urinary bladder cancer. Urol Int 1994;53:125–129.
   Google Scholar
• Anwar K, Naiki H, Nakakuki K, Inuzuka M. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 1992;70:1967–1973.
   Google Scholar
• Ashfaq R, Vuitch F. Human papillomavirus and carcinomas of the female urethra. J Urol Pathol 1994;2:195–201.
   Google Scholar
• Bryant P, Davies P, Wilson D. Detection of human papillomavirus DNA in cancer of the urinary bladder by in situ hybridisation. Br J Urol 1991;68:49–52.
   Google Scholar
• Chetsanga C, Malmström PU, Gyllensten U, Low incidence of human papillomavirus type 16 DNA in bladder tumor detected by the polymerase chain reaction. Cancer 1992;69:1208–1211.
   Google Scholar
• Furihata M, Inoue K, Ohtsuki Y, High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res 1993;53:4823–4827.
   Google Scholar
• Gopalkrishna V, Srivastava AN, Hedau S, Detection of human papillomavirus DNA sequences in cancer of the urinary bladder by in situ hybridisation and polymerase chain reaction. Genitourin Med 1995;71:231–233.
   Google Scholar
• Kamel D, Pääkkö P, Pöllänen R, Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder. APMIS Acta Pathol. Microbiol Immunol Scand 1995;103:331–338.
   Google Scholar
• Kerley SW, Persons DL, Fishback JL. Human papillomavirus and carcinoma of the urinary bladder. Mod Pathol Off J United States Can Acad Pathol Inc 1991;4:316–319.
   Google Scholar
• Kim KH, Kim YS. Analysis of p53 tumor suppressor gene mutations and human papillomavirus infection in human bladder cancers. Yonsei Med J 1995;36:322–331.
   Google Scholar
• LaRue, Simoneau, Fradet. Human papillomavirus in transitional cell carcinoma of the urinary bladder. Clin Cancer Res Off J Am Assoc Cancer Res 1995;1:435–440.
   Google Scholar
• Lopez-Beltran A, Escudero AL, Vicioso L, Human papillomavirus DNA as a factor determining the survival of bladder cancer patients. Br J Cancer 1996;73:124–127.
   PubMed Web of Science ®Google Scholar
• Lopez-Beltran A, Muñoz E. Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridization. Histopathology 1995;26:565–569.
   Google Scholar
• Maloney KE, Wiener JS, Walther PJ. Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: evaluation by differential polymerase chain reaction. J Urol 1994;151:360–364.
   Google Scholar
• Mvula M, Iwasaka T, Iguchi A, Do human papillomaviruses have a role in the pathogenesis of bladder carcinoma? J Urol 1996;155:471–474.
   PubMed Web of Science ®Google Scholar
• Noel JC, Thiry L, Verhest A, Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. Urology 1994;44:671–675.
   Google Scholar
• Ben Selma W, Ziadi S, Ben Gacem R, Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients. Pathol Res Pract 2010;206:740–743.
   Google Scholar
• Barghi MR, Hajimohammadmehdiarbab A, Moghaddam SMMH, Kazemi B. Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis 2005;5:102.
   Google Scholar
• Gutiérrez J, Jiménez A, de Dios Luna J, Meta-analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus. J Urol 2006;176:2474–2481; discussion 2481.
   PubMed Web of Science ®Google Scholar
• Jiménez Pacheco A, Martínez Torres JI, Pareja Vilchez M, Statistical analysis of the influence of the virus of papilloma human in the development of the vesical carcinoma. Actas Urol Españolas 2007;31:469–476.
   Google Scholar
• Li N, Yang L, Zhang Y, Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis 2011;204:217–223.
   PubMed Web of Science ®Google Scholar
• Jimenez-Pacheco A, Exposito-Ruiz M, Arrabal-Polo MA, Lopez-Luque AJ. Meta-analysis of studies analyzing the role of human papillomavirus in the development of bladder carcinoma. Korean J Urol 2012;53:240–247.
   PubMedGoogle Scholar
• Gopalkrishna V, Singh UR, Sodhani P, Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat 1996;39:197–202.
   PubMed Web of Science ®Google Scholar
• Hedau S, Kumar U, Hussain S, Breast cancer and human papillomavirus infection: no evidence of HPV etiology of breast cancer in Indian women. BMC Cancer 2011;11:27.
   Google Scholar
• Silva RG Jr, da Silva BB. No evidence for an association of human papillomavirus and breast carcinoma. Breast Cancer Res Treat 2011;125:261–264.
   Google Scholar
• Mendizabal-Ruiz AP, Morales JA, Ramírez-Jirano LJ, Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat 2009;114:189–194.
   Google Scholar
• Baltzell K, Buehring GC, Krishnamurthy S, Limited evidence of human papillomavirus in [corrected] breast tissue using molecular in situ methods. Cancer. 2012;118:1212–1220.
   Google Scholar
• Yasmeen A, Bismar TA, Kandouz M, E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle Georget Tex 2007;6:2038–2042.
   PubMed Web of Science ®Google Scholar
• Antonsson A, Spurr TP, Chen AC, High prevalence of human papillomaviruses in fresh frozen breast cancer samples. J Med Virol 2011;83:2157–2163.
   Google Scholar
• Khan NA, Castillo A, Koriyama C, Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer 2008;99:408–414.
   Google Scholar
• Haedicke J, Iftner T. Human papillomaviruses and cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol 2013;108:397–402.
   PubMed Web of Science ®Google Scholar
• Cobb MW. Human papillomavirus infection. J Am Acad Dermatol 1990;22:547–566.
   PubMed Web of Science ®Google Scholar
• Iannacone MR, Gheit T, Waterboer T, Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin. J Invest Dermatol 2013;133:1512–1520.
   Google Scholar
• Zakrzewska K, Regalbuto E, Pierucci F, Pattern of HPV infection in basal cell carcinoma and in perilesional skin biopsies from immunocompetent patients. Virol J 2012;9:309.
   Google Scholar
• Iannacone MR, Gheit T, Waterboer T, Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol. Biomarkers Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 2012;21:1303–1313.
   Google Scholar
• Farzan SF, Waterboer T, Gui J, Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study. Int J Cancer 2013;133:1713–1720.
   Google Scholar
• Andersson K, Luostarinen T, Strand AS, Prospective study of genital human papillomaviruses and nonmelanoma skin cancer. Int J Cancer 2013;133:1840–1845.
   Google Scholar
• Massad LS, Einstein M, Myers E, The impact of human papillomavirus vaccination on cervical cancer prevention efforts. Gynecol Oncol 2009;114:360–364.
   Google Scholar
• Hakim AA, Dinh TA. Worldwide impact of the human papillomavirus vaccine. Curr Treat Options Oncol 2009;10:44–53.
   Google Scholar
• Katz ML, Reiter PL, Kluhsman BC, Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states. Vaccine 2009;27:3195–3200.
   PubMed Web of Science ®Google Scholar
• GARDASIL - Summary of Product Characteristics (SPC) - (eMC) [Internet]. Sanofi Pasteur MSD. 2011. Available from: http://www.medicines.org.uk/emc/medicine/19016/SPC/gardasil/
   Google Scholar
• Hendrix SL. Assessing human papillomavirus vaccine efficacy and safety. J Am Osteopath Assoc 2008;108:S8–S12.
   Google Scholar
• Highlights of Prescribing Information for Gardasil. Merck & Co., Inc.
   Google Scholar
• Cervarix FDA Approval History - Drugs.com [Internet]. Drug Inf Online. [cited 2013 May 18]. Available from: http://www.drugs.com/history/cervarix.html
   Google Scholar
• FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine [Internet]. Drug Inf Online. 2009 [cited 2013 May 18]. Available from: http://www.drugs.com/newdrugs/fda-approves-cervarix-glaxosmithkline-s-cervical-cancer-vaccine-1690.html
   Google Scholar
• National Drug Monograph-Human Papillomavirus Types 16/18 Recombinant Vaccine (Cevarix). VA Pharmacy Benefits Management Services, Medical Advisory Panel and VISN Pharmacist Executives; 2011.
   Google Scholar
• Human Papillomavirus (HPV) Vaccines - National Cancer Institute [Internet]. Hum Papillomavirus HPV Vaccines 2011 [cited 2013 May 19]. Available from: http://www.cancer.gov/cancertopics/ factsheet/Prevention/HPV-vaccine
   Google Scholar
• Borysiewicz LK, Fiander A, Nimako M, A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 1996;347:1523–1527.
   PubMed Web of Science ®Google Scholar
• Chu NR, Wu HB, Wu T, Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7. Clin Exp Immunol 2000;121:216–225.
   PubMed Web of Science ®Google Scholar
• Gomez-Gutierrez JG, Elpek KG, Montes de Oca-Luna R, Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice. Cancer Immunol Immunother CII. 2007;56:997–1007.
   PubMed Web of Science ®Google Scholar
• Khairunadwa J, Young V, Wilson M, An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy. PLoS ONE 2013;8(6):e66866.
   Google Scholar
• Sadraeian M, Khoshnood Mansoorkhani MJ, Prevention and inhibition of TC-1 cell growth in tumor bearing mice by HPV16 E7 protein in fusion with shiga toxin B-Subunit from shigella dysenteriae. Cell J 2013;15:176–181.
   Google Scholar
• D'Souza G, Dempsey A. The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med 2011;53 (Suppl 1):S5–S11.
   PubMedGoogle Scholar
• Anhang R, Goodman A, Goldie SJ. HPV communication: review of existing research and recommendations for patient education. CA. Cancer J Clin 2004;54:248–259.
   Google Scholar
• Gelman A, Nikolajski C, Schwarz EB, Borrero S. Racial disparities in awareness of the human papillomavirus. J Womens Heal 2002. 2011;20:1165–1173.
   Google Scholar
• Rodriguez M. Is increasing HPV infection awareness promoting increased vaccine compliance? Internet J Adv Nurs Pr [Internet] 2010 [cited 2013 Jul 3];11. Available from: http://www. ispub.com/doi/10.5580/295a
   Google Scholar
• Liu Y, Klimberg VS, Andrews NR, Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol 2001;4:329–334.
   PubMedGoogle Scholar